Placebo Control
A review of key issues in pharmaceutical clinical trials
Showing posts with label
GSK
.
Show all posts
Showing posts with label
GSK
.
Show all posts
Tuesday, June 4, 2013
Can FDA's New Transparency Survive Avandia?
›
PDUFA V commitments signal a strong commitment to tolerance of open debate in the face of uncertainty. I can admit to a rather powerful la...
Wednesday, February 6, 2013
Our New Glass House: GSK's Commitment to AllTrials
›
No stones, please. Yesterday, Alec Gaffney was kind enough to ask my opinion on GSK's signing on to the AllTrials initiative to b...
›
Home
View web version
